Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
14,578,989
-
Share change
-
-653,820
-
Total reported value
-
$72,890,000
-
Price per share
-
$5.00
-
Number of holders
-
42
-
Value change
-
-$3,282,605
-
Number of buys
-
14
-
Number of sells
-
18
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2018
As of 30 Jun 2018,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,578,989 shares.
The largest 10 holders included
Paradice Investment Management LLC, Russell Investments Group, Ltd., JANUS HENDERSON GROUP PLC, Lapides Asset Management, LLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, Senvest Management, LLC, 22NW, LP, HEARTLAND ADVISORS INC, Boston Partners, and HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.